ונקו-טבע 1 גר'

Nazione: Israele

Lingua: ebraico

Fonte: Ministry of Health

Principio attivo:

VANCOMYCIN AS HYDROCHLORIDE

Commercializzato da:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

Codice ATC:

A07AA09

Forma farmaceutica:

אבקה מיובשת בהקפאה להזרקה

Composizione:

VANCOMYCIN AS HYDROCHLORIDE 1 G/VIAL

Via di somministrazione:

תוך-ורידי

Tipo di ricetta:

מרשם נדרש

Prodotto da:

TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY, HUNGARY

Gruppo terapeutico:

VANCOMYCIN

Area terapeutica:

VANCOMYCIN

Indicazioni terapeutiche:

Vancomycin hydrochloride is indicated for the treatment of severe or serious infections due to susceptible strains of methicillin - resistant (beta-Iactam-resistant) staphylococci. It is also indicated for administration to penicillin-allergic patients as well patients who have failed to respond to or who cannot receive other drugs including cephalosporins or penicillins and for infections due to vancomycin-susceptible organisms that are resistant to other antimicrobial drugs. Vancomycin hydrochloride is indicated for first-line therapy when methicillin-resistant staphylococci are suspected but when susceptibility data become available appropriate therapy should be instituted. Vancomycin hydrochloride is effective in the treatment of staphylococcal endocarditis as well as in other infections due to staphylococci including lower respiratory tract infections septicemia skin and skin - stucture infection and bone infections. Antibiotic therapy is as an adjunct to appropriate surgical measures when staphylococcal

Data dell'autorizzazione:

2010-11-30